Regulation of adenosine levels during cerebral ischemia

Acta Pharmacologica Sinica

Volumn 34, Issue 1, 2013, Pages 60-66

  Chu, Stephanie ^a   Xiong, Wei ^a   Zhang, Dali ^a   Soylu, Hanifi ^a   Sun, Chao ^a   Albensi, Benedict C ^a,b   Parkinson, Fiona E ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

adenosine; ATP; cerebral ischemia; hENT1 transgenic mice; hippocampus; nucleoside transport

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ENDOTHELIN 1; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; NUCLEOSIDE TRANSPORTER;

ASTROCYTE; BIOASSAY; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL CULTURE; CELL MEMBRANE; CELL METABOLISM; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HUMAN; NEUROMODULATION; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; BRAIN ISCHEMIA; HUMANS; NEURONS; NUCLEOSIDE TRANSPORT PROTEINS;

EID: 84872065655     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.127     Document Type: Review

References (36)

1. Camici M, Micheli V, Ipata PL, Tozzi MG. Pediatric neurological syndromes and inborn errors of purine metabolism. Neurochem Int 2010;56:367-78.
2. Dunwiddie TV, Masino SA. The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 2001;24:31-55. (Pubitemid 32695222)
3. Newby AC, Worku Y, Holmquist CA. Adenosine formation. Evidence for a direct biochemical link with energy metabolism. Adv Myocardiol 1985;6:273-84.
4. Phillis JW. The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil. Brain Res 1995;705:79-84.
5. Melani A, Pantoni L, Bordoni F, Gianfriddo M, Bianchi L, Vannucchi MG, et al. The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat. Brain Res 2003;959:243-50. (Pubitemid 35472186)
6. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005;280:20493-502. (Pubitemid 40776749)
7. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012;13:251-62.
8. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD. Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007;38:2992-9. (Pubitemid 350035695)
9. Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005;310:113-6. (Pubitemid 41434548)
10. Zhang JM, Wang HK, Ye CQ, Ge W, Chen Y, Jiang ZL, et al. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 2003;40:971-82. (Pubitemid 37522054)
11. Huxtable AG, Zwicker JD, Poon BY, Pagliardini S, Vrouwe SQ, Greer JJ, et al. Tripartite purinergic modulation of central respiratory networks during perinatal development: the influence of ATP, ectonucleotidases, and ATP metabolites. J Neurosci 2009;29:14713-25.
12. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov 2008;7:575-90. (Pubitemid 351927723)
13. Parkinson FE, Damaraju VL, Graham K, Yao S Y M, Baldwin SA, Cass CE, et al. Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr Top Med Chem 2011;11:948-72.
14. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, et al. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 2005;280:15880-7. (Pubitemid 40616710)
15. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, et al. Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 2006;99:510-9. (Pubitemid 44337823)
16. Choi DS, Cascini MG, Mailliard W, Young H, Paredes P, McMahon T, et al. The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference. Nat Neurosci 2004;7:855-61. (Pubitemid 38989509)
17. Nam HW, Lee MR, Zhu Y, Wu J, Hinton DJ, Choi S, et al. Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling. Biol Psychiatry 2011;69:1043-51.
18. Rose JB, Naydenova Z, Bang A, Ramadan A, Klawitter J, Schram K, et al. Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge. Life Sci 2011;89:621-30.
19. Rose JB, Naydenova Z, Bang A, Eguchi M, Sweeney G, Choi DS, et al. Equilibrative nucleoside transporter 1 plays an essential role in cardioprotection. Am J Physiol Heart Circ Physiol 2010;298:H771-7.
20. Parkinson FE, Xiong W. Stimulus-and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J Neurochem 2004;88:1305-12. (Pubitemid 38280698)
21. Zamzow CR, Xiong W, Parkinson FE. Adenosine produced by neurons is metabolized to hypoxanthine by astrocytes. J Neurosci Res 2008;86:3447-55.
22. Zamzow CR, Xiong W, Parkinson FE. Astrocytes affect the profile of purines released from cultured cortical neurons. J Neurosci Res 2008;86:2641-9.
23. Parkinson FE, Xiong W, Zamzow CR, Chestley T, Mizuno T, Duckworth ML. Transgenic expression of human equilibrative nucleoside transporter 1. in mouse neurons. J Neurochem 2009;109:562-72.
24. Zhang D, Xiong W, Albensi BC, Parkinson FE. Expression of human equilibrative nucleoside transporter 1 in mouse neurons regulates adenosine levels in physiological and hypoxic-ischemic conditions. J Neurochem 2011;118:4-11.
25. Etherington LA, Patterson GE, Meechan L, Boison D, Irving AJ, Dale N, et al. Astrocytic adenosine kinase regulates basal synaptic adenosine levels and seizure activity but not activity-dependent adenosine release in the hippocampus. Neuropharmacology 2009;56:429-37.
26. Dunwiddie TV, Diao L. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J Pharmacol Exp Ther 1994;268:537-45. (Pubitemid 24085843)
27. Frenguelli BG, Llaudet E, Dale N. High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J Neurochem 2003;86:1506-15. (Pubitemid 37174267)
28. Pearson T, Damian K, Lynas RE, Frenguelli BG. Sustained elevation of extracellular adenosine and activation of A receptors underlie the post-ischaemic inhibition of neuronal function in rat hippocampus in vitro. J Neurochem 2006;97:1357-68. (Pubitemid 43725575)
29. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A 2001;98:9407-12. (Pubitemid 32743930)
30. Frenguelli BG, Wigmore G, Llaudet E, Dale N. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J Neurochem 2007;101:1400-13. (Pubitemid 46718811)
31. Windle V, Szymanska A, Granter-Button S, White C, Buist R, Peeling J, et al. An analysis of four different methods of producing focal cerebral ischemia with endothelin-1 in the rat. Exp Neurol 2006;201:324-34. (Pubitemid 44344225)
32. Siesjo BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992;77:169-84.
33. Soylu H, Zhang D, Buist R, Martin M, Albensi BC, Parkinson FE. Intracortical injection of endothelin-1 induces cortical infarcts in mice: effect of neuronal expression of an adenosine transporter. Exp Transl Stroke Med 2012;4:4.
34. Rudolphi KA, Schubert P, Parkinson FE, Fredholm BB. Adenosine and brain ischemia. Cerebrovasc Brain Metab Rev 1992;4:346-69.
35. Masino SA, Diao L, Illes P, Zahniser NR, Larson GA, Johansson B, et al. Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a (1) receptors. J Pharmacol Exp Ther 2002;303:356-63.
36. Parkinson FE, Xiong W, Zamzow CR. Astrocytes and neurons: different roles in regulating adenosine levels. Neurol Res 2005;27:153-60. (Pubitemid 40388420)